Stimulus-Coupled Spatial Restriction of Extracellular Signal-Regulated Kinase 1/2 Activity Contributes to the Specificity of Signal-Response Pathways

REFERENCES

• Adachi, M., Fukuda M., and Nishida E.. 2000. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J. Cell Biol. 148:849–856.
   PubMed Web of Science ®Google Scholar
• Boulton, T. G., and Cobb M. H.. 1991. Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul. 2:357–371.
   PubMedGoogle Scholar
• Brunet, A., Roux D., Lenormand P., Dowd S., Keyse S., and Pouyssegur J.. 1999. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18:664–674.
   PubMed Web of Science ®Google Scholar
• Chen, R.-H., Sarnecki C., and Blenis J.. 1992. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol. Cell. Biol. 12:915–927.
   PubMed Web of Science ®Google Scholar
• Dalby, K. N., Morrice N., Caudwell F. B., Avruch J., and Cohen P.. 1998. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273:1496–1505.
   PubMed Web of Science ®Google Scholar
• Ferrell, J. E., Jr., and Machleder E. M.. 1998. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280:895–898.
   PubMed Web of Science ®Google Scholar
• Formstecher, E., Ramos J. W., Fauquest M., Calderwood D. A., Hseih J. C., Canton B., Nguyen X. T., Barnier J. V., Camonis J., Ginsberg M. H., and Chneiweiss H.. 2001. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1:239–250.
   PubMed Web of Science ®Google Scholar
• Gavin, A.-C., and Nebreda A. R.. 1999. A MAP kinase docking site is required for phosphorylation and activation of p90rsk/MAPKAP kinase-1. Curr. Biol. 9:281–284.
   PubMed Web of Science ®Google Scholar
• Gille, H., Kortenjann M., Thomae O., Moomaw C., Slaughter C., Cobb M. H., and Shaw P. E.. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14:951–962.
   PubMed Web of Science ®Google Scholar
• Gupta, S., and Davis R. J.. 1994. MAP kinase binds to the NH2-terminal activation domain of c-Myc. FEBS Lett. 353:281–285.
   PubMedGoogle Scholar
• Hsiao, K., Chou S., Shih S., and Ferrell J., Jr. 1994. Evidence that inactive p42 mitogen-activated protein kinase and inactive Rsk exist as a heterodimer in vivo. Proc. Natl. Acad. Sci. USA 91:5480–5484.
   PubMedGoogle Scholar
• Janknecht, R., Ernst W., Pingoud V., and Nordheim A.. 1993. Activation of ternary complex factor Elk-1 by MAP kinases. EMBO J. 12:5097–5104.
   PubMed Web of Science ®Google Scholar
• Kao, S., Jaiswal R. K., Kolch W., and Landreth G. E.. 2001. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276:18169–18177.
   PubMed Web of Science ®Google Scholar
• Klemke, R. L., Cai S., Giannini A. L., Gallagher P. J., de Lanerolle P., and Cheresh D. A.. 1997. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137:481–492.
   PubMed Web of Science ®Google Scholar
• Lavoie, J. N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J.. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608–20616.
   PubMed Web of Science ®Google Scholar
• Lewis, T. S., Shapiro P. S., and Ahn N. G.. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
   PubMed Web of Science ®Google Scholar
• Lin, L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A., and Davis R. J.. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269–278.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• Menice, C. B., Hulvershorn J., Adam L. P., Wang C.-L. A., and Morgan K.. 1997. Calponin and mitogen-activated protein kinase signaling in differentiated vascular smooth muscle. J. Biol. Chem. 272:25157–25161.
   PubMedGoogle Scholar
• Murphy, L. O., MacKeigan J. P., and Blenis J.. 2004. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol. Cell. Biol. 24:144–153.
   PubMed Web of Science ®Google Scholar
• Murphy, L. O., Smith S., Chen R. H., Fingar D. C., and Blenis J.. 2002. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4:556–564.
   PubMed Web of Science ®Google Scholar
• Nguyen, A., Burack W. R., Stock J. L., Kortum R., Chaika O. V., Afkarian M., Muller W. J., Murphy K. M., Morrison D. K., Lewis R. E., McNeish J., and Shaw A. S.. 2002. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell. Biol. 22:3035–3045.
   PubMed Web of Science ®Google Scholar
• Pearson, G., Robinson F., Beers Gibson T., Xu B. E., Karandikar M., Berman K., and Cobb M. H.. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22:153–183.
   PubMed Web of Science ®Google Scholar
• Robinson, M. J., Stippec S. A., Goldsmith E., White M. A., and Cobb M. H.. 1998. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8:1141–1150.
   PubMed Web of Science ®Google Scholar
• Traverse, S., Gomez N., Paterson H., Marshall C., and Cohen P.. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:351–355.
   PubMed Web of Science ®Google Scholar
• Vial, E., and Marshall C. J.. 2003. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J. Cell Sci. 116:4957–4963.
   PubMedGoogle Scholar